Cellectis S.A. ADR (NQ: CLLS )

13.33 USD -0.29 (-2.13%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2021 Add to My Watchlist

Price and Volume

Volume	231,027
Open	13.72
Bid (Size)	13.18 (15)
Ask (Size)	13.34 (9)
Prev. Close	13.62
Today's Range	13.07 - 14.02
52wk Range	12.55 - 34.71
Shares Outstanding	42,780,186
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT

July 29, 2021

Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities

June 14, 2021

Performance

YTD	-51.70%	-51.70%
1 Month	-10.30%	-10.30%
3 Month	-21.54%	-21.54%
6 Month	-53.86%	-53.86%
1 Year	-23.79%	-23.79%

More News

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021

June 02, 2021

Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T

May 11, 2021

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021

May 06, 2021

12 Health Care Stocks Moving In Monday's Pre-Market Session

July 12, 2021

The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century

July 01, 2021

Sum Up The Parts: KOMP Could Be Worth $76

June 16, 2021

Cellectis Unveils Four Additional Preclinical Candidates For Solid Tumors

June 15, 2021

Analysts Predict 29% Gains Ahead For KOMP

May 13, 2021

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal

July 28, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.